Latest Regulatory News

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Clarity Pharmaceuticals will present compelling data on its 64Cu-SAR-bisPSMA diagnostic agent at two leading oncology conferences, highlighting earlier and more accurate prostate cancer lesion detection than current standards.

OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.

3D Energi Limited is progressing rapidly towards its 2025 Otway Exploration Drilling Program, with key preparations underway and regulatory approvals advancing, positioning the company to potentially capitalise on East Coast Australia's critical gas supply shortage.

Fitzroy River Corporation's latest quarterly report reveals a dip in royalty income but highlights progress on major silver and gold projects, alongside strategic moves in energy royalties.

Leeuwin Metals Limited (ASX:LM1) has secured a transformative acquisition of the Marda Gold Project, significantly enhancing its portfolio with a high-grade gold asset in Western Australia. The company also announced a $3.25 million capital raising to fund extensive exploration across its Australian and Canadian projects.

Energy Resources of Australia Limited reported a substantial net cash outflow of $183.9 million in Q4 2024, driven by significant rehabilitation payments, while raising $766.5 million through equity to bolster its cash position.

Energy Resources of Australia (ERA) reports a robust cash position following a $766 million entitlement offer, advancing rehabilitation at its Ranger Project while seeking to extend its operational authority beyond January 2026.

IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

DomaCom Limited reported a steep $4.5 million loss for the half-year ending December 2023, driven by declining revenues and operational hurdles, including a temporary suspension of its fund's Product Disclosure Statement. The company is actively pursuing capital raises to stabilize its position.

Osmond Resources has reported strong assay results from 27 samples at its Orion EU Critical Minerals Project in Spain, highlighting promising high-grade mineralization and continuity between zones. The company is poised to commence drilling to confirm these findings and accelerate development.